To address the growing use of ad blockers we now use affiliate links to sites like Amazon.com, streaming services, and others. Affiliate links help sites like QualityCounts.com stay open. Affiliate links cost you nothing but help me support my family. We do not allow paid reviews on this site. As an Amazon Associate I earn from qualifying purchases.  Also, you can donate  to ben@qualitycounts.com via Zelle or PayPal.  Click here for the PayPal QR.  Click here for Bitcoin QR code or Bitcoin address: 39muDw6WpQV8j6EdA8eUBvT5iFDiVpVpiE
Home ReliableRXPharmacy Past Newsletters Amazon.com Contact
 Sign-up for newsletter 
 Newsletter Archive
 Newsletter via RSS Feed
 Research on Supplements
 Health Conditions
 Anti-aging Recommendations
 Insulin and Aging
 QualityCounts.com in Time
 Longevity Affiliates:

Home > Health Conditions > Weight Control > Wegovy (semaglutide)


News & Research:

  • FDA approves new obesity drug for long-term weight management - CBS, 6/21/21 - "In clinical trials, patients receiving the weekly injection had an average weight loss of 15% and steadily lost weight over the 16-month study period. Importantly, these results are close to those for patients who have bariatric surgery, and they are far better than those seen from other weight loss drugs currently on the market ... Novo Nordisk‚Äôs obesity drug Wegovy (semaglutide) is the first approved drug for chronic weight management in adults with general obesity or overweight with at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol, since 2014 ... Wegovy is a synthesized version of a gut hormone that curbs appetite. It is to be injected under the skin once-weekly"